Search research articles
Contact Us
Filters
Showing results (171-180 of 505) with videos related to
Page
of 51
Sort By:
Respiratory Medicine
|
April 8, 2026
Safety and tolerability of the low global warming potential propellant HFA-152a in patients with asthma receiving beclometasone dipropionate/formoterol fumarate/glycopyrronium: The TRECOS study
Dave Singh, Lorenzo Mancini, Giada Melis, et al.
Puerto Rico Health Sciences Journal
|
August 4, 2006
Associations between a history of breast feeding, malocclusion and parafunctional habits in Puerto Rican children
Lydia M López Del Valle, G Dave Singh, Nilma Feliciano, et al.
Respiratory Medicine
|
September 2, 2008
Impulse oscillometry in COPD: identification of measurements related to airway obstruction, airway conductance and lung volumes
Umme Kolsum, Zoë Borrill, Kay Roy, et al.
Cytokine
|
June 24, 2018
Anti-inflammatory effects of the phosphodiesterase type 4 inhibitor CHF6001 on bronchoalveolar lavage lymphocytes from asthma patients
Thomas Southworth, Manminder Kaur, Lynsey Hodgson, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
July 27, 2017
Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 study
Dave Singh, Mario Scuri, Sara Collarini, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
September 1, 2020
Usability and Robustness of the Wixela Inhub Dry Powder Inhaler
Richard Allan, Kelly Canham, Roisin Wallace, et al.
Pulmonary Pharmacology & Therapeutics
|
March 7, 2008
Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients
Dave Singh, Annalisa Piccinno, Zoe Borrill, et al.
Advances in Therapy
|
March 10, 2026
Inhaled Corticosteroid/Long-Acting β<sub>2</sub>-Agonist Selection for Patients with Moderate-to-Severe Asthma: Considerations for Real-World Practice, A Narrative Review
John D Blakey, Lorenzo Cecchi, Christian Domingo, et al.
Respiratory Research
|
January 12, 2020
Reduced risk of clinically important deteriorations by ICS in COPD is eosinophil dependent: a pooled post-hoc analysis
Mona Bafadhel, Dave Singh, Christine Jenkins, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 2, 2016
Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease
Dave Singh, Nicolas Roche, David Halpin, et al.
Page
of 51
Search research articles
Search
Showing results (171-180 of 505) with videos related to
Sort By:
Page
of 51
Respiratory Medicine
|
April 8, 2026
Safety and tolerability of the low global warming potential propellant HFA-152a in patients with asthma receiving beclometasone dipropionate/formoterol fumarate/glycopyrronium: The TRECOS study
Dave Singh, Lorenzo Mancini, Giada Melis, et al.
Puerto Rico Health Sciences Journal
|
August 4, 2006
Associations between a history of breast feeding, malocclusion and parafunctional habits in Puerto Rican children
Lydia M López Del Valle, G Dave Singh, Nilma Feliciano, et al.
Respiratory Medicine
|
September 2, 2008
Impulse oscillometry in COPD: identification of measurements related to airway obstruction, airway conductance and lung volumes
Umme Kolsum, Zoë Borrill, Kay Roy, et al.
Cytokine
|
June 24, 2018
Anti-inflammatory effects of the phosphodiesterase type 4 inhibitor CHF6001 on bronchoalveolar lavage lymphocytes from asthma patients
Thomas Southworth, Manminder Kaur, Lynsey Hodgson, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
July 27, 2017
Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 study
Dave Singh, Mario Scuri, Sara Collarini, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
September 1, 2020
Usability and Robustness of the Wixela Inhub Dry Powder Inhaler
Richard Allan, Kelly Canham, Roisin Wallace, et al.
Pulmonary Pharmacology & Therapeutics
|
March 7, 2008
Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients
Dave Singh, Annalisa Piccinno, Zoe Borrill, et al.
Advances in Therapy
|
March 10, 2026
Inhaled Corticosteroid/Long-Acting β<sub>2</sub>-Agonist Selection for Patients with Moderate-to-Severe Asthma: Considerations for Real-World Practice, A Narrative Review
John D Blakey, Lorenzo Cecchi, Christian Domingo, et al.
Respiratory Research
|
January 12, 2020
Reduced risk of clinically important deteriorations by ICS in COPD is eosinophil dependent: a pooled post-hoc analysis
Mona Bafadhel, Dave Singh, Christine Jenkins, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 2, 2016
Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease
Dave Singh, Nicolas Roche, David Halpin, et al.
Page
of 51